Key result
Multidisciplinary pharmacologic and nonpharmacologic management is essential to minimize cardiogenic shock morbidity and mortality.
Cardiogenic shock requires a multidisciplinary approach in a critical care setting using both pharmacologic and nonpharmacologic therapies to minimize morbidity and mortality.
Answers are grounded in this paper and cite their sources.
Multidisciplinary cardiogenic shock care warrants consideration now; leaves open optimal therapy integration for prospective trials.
Cardiogenic shock (CS) is a complex condition characterized by end-organ hypoperfusion and requiring pharmacologic and/or mechanical circulatory support. It is caused by a decline in cardiac output due to a primary cardiac disorder. CS is frequently complicated by multiorgan system dysfunction that requires a multidisciplinary approach in a critical care setting. Appropriate use of diagnostic data using tools available in a modern cardiac intensive care unit should guide optimal management incorporating both pharmacologic and nonpharmacologic therapies to minimize morbidity and mortality.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted a review in Cardiogenic shock. Multidisciplinary management strategies was evaluated. Optimal management of cardiogenic shock requires a multidisciplinary approach incorporating both pharmacologic and nonpharmacologic therapies to minimize morbidity and mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: